{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":26,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":26,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"9a43560aa3fc","filters":{"venue":"Pharmaceutical Medicine"}},"results":[{"id":"W1883456152","doi":"10.1007/s40290-015-0106-6","title":"Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US","year":2015,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"U.S. Food and Drug Administration; Hamilton Health Sciences Foundation","keywords":"Pharmacovigilance; Outreach; Adverse effect; Medicine; Event (particle physics); Adverse drug event; Medical emergency; Medical physics; Internal medicine","authors":[{"name":"Chi Bahk","is_ca":false},{"name":"Melanie Goshgarian","is_ca":false},{"name":"Krystal Donahue","is_ca":false},{"name":"Clark C. Freifeld","is_ca":false},{"name":"Christopher M. Menone","is_ca":false},{"name":"Carrie E. Pierce","is_ca":false},{"name":"Harold Rodriguez","is_ca":false},{"name":"John S. Brownstein","is_ca":false},{"name":"Robert Furberg","is_ca":false},{"name":"Nabarun Dasgupta","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4049343292784165,"gpt":0.5660667458406965,"spread":0.16113241656228,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007565435,0.0003425159,0.0004142759,0.002893447,0.001153377,0.001755239,0.0008354994,0.0008664758,0.002219715],"category_scores_gemma":[0.03478308,0.0003750848,0.00119512,0.003412523,0.0007454473,0.002232706,0.00316922,0.001462042,0.0003278436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001674901,"about_ca_system_score_gemma":0.003855809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01938832,"about_ca_topic_score_gemma":0.02296534,"domain_scores_codex":[0.9909177,0.00450872,0.001035642,0.0006003387,0.001894906,0.001042781],"domain_scores_gemma":[0.9727471,0.01205402,0.00879157,0.00106915,0.003086215,0.002251983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005302458,0.0007478419,0.9534995,0.0001955079,0.0001785613,0.0002066582,0.01061796,0.0001348006,0.0002235796,0.0001944614,0.001247494,0.03222333],"study_design_scores_gemma":[0.00003170923,0.0005413889,0.9860875,0.0001333122,0.0000741938,0.0001828522,0.01037902,0.0009465549,0.0001263691,0.00008957447,0.001383828,0.00002363641],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975842,0.0002115597,0.0002841221,0.0004678504,0.000005484143,0.0001631147,0.0004155425,0.00001264452,0.000855569],"genre_scores_gemma":[0.9976032,0.0003272743,0.0005976494,0.0003614173,0.00001366224,0.000226897,0.0004852965,0.00001623555,0.0003684026],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01938832,"threshold_uncertainty_score":0.04001033,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3193700822","doi":"10.1007/s40290-021-00397-6","title":"The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic","year":2021,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Authorization; Pandemic; Coronavirus disease 2019 (COVID-19); Medical emergency; 2019-20 coronavirus outbreak; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Business; Computer security; Virology; Infectious disease (medical specialty); Disease; Outbreak; Computer science","authors":[{"name":"Allan Tran","is_ca":true},{"name":"Theodore J. Witek","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4623289032833736,"gpt":0.5408226501648542,"spread":0.07849374688148059,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003091849,0.0008392099,0.002012638,0.003289932,0.0004481248,0.002872572,0.001216447,0.003296769,0.005636695],"category_scores_gemma":[0.006836466,0.0004710062,0.001326404,0.003980986,0.00148488,0.002947386,0.001231663,0.004689935,0.001327544],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002469482,"about_ca_system_score_gemma":0.005338362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005095091,"about_ca_topic_score_gemma":0.01155302,"domain_scores_codex":[0.9989145,0.0003057984,0.0001535828,0.0001602746,0.000364093,0.0001017044],"domain_scores_gemma":[0.992326,0.005391168,0.001040183,0.0001075139,0.0008705817,0.0002646772],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001649062,0.00005673106,0.0002279552,0.01857157,0.0001702738,0.0001423517,0.00009775809,0.0003660788,0.000350869,0.0112583,0.03856436,0.9300289],"study_design_scores_gemma":[0.00005335384,0.00009679992,0.001057821,0.01560379,0.0002118808,0.0005620263,0.00008605237,0.0001063038,0.0001502486,0.002278537,0.9797658,0.00002740766],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005765555,0.9983168,0.00003926173,0.0006658611,0.0001189278,0.000002784853,0.00001969701,0.000002934268,0.0007761914],"genre_scores_gemma":[0.000824753,0.9977863,0.0001047226,0.0008153492,0.0002132212,0.000004286056,0.00002152257,0.000001600006,0.0002283293],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005636695,"threshold_uncertainty_score":0.01885659,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3010852553","doi":"10.1007/s40290-020-00329-w","title":"US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)","year":2020,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Adverse Event Reporting System; Food and drug administration; Adverse effect; Medicine; Drug; Food safety; Environmental health; Emergency medicine; Pharmacology","authors":[{"name":"Thomas J. Moore","is_ca":false},{"name":"Richard L. Morrow","is_ca":true},{"name":"Colin R. Dormuth","is_ca":true},{"name":"Barbara Mintzes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2034564212299265,"gpt":0.4756487230022144,"spread":0.2721923017722879,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02259462,0.001139287,0.001663258,0.008200706,0.001284708,0.003712856,0.002240312,0.003843467,0.02633298],"category_scores_gemma":[0.106617,0.0007464368,0.002062071,0.007263737,0.0007794797,0.001885653,0.001468904,0.00398992,0.01269512],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002867168,"about_ca_system_score_gemma":0.01519787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01539451,"about_ca_topic_score_gemma":0.008883152,"domain_scores_codex":[0.9713032,0.00961176,0.006873548,0.001491938,0.009710562,0.001008933],"domain_scores_gemma":[0.8070846,0.04751614,0.04509468,0.01468462,0.08114378,0.00447627],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008955348,0.0008544763,0.03555717,0.002002916,0.0005180546,0.0003077994,0.0002268092,0.001448835,0.003797287,0.009034003,0.6755273,0.2698298],"study_design_scores_gemma":[0.0008097459,0.0007796226,0.08687391,0.002185274,0.0006552602,0.001132815,0.0002134388,0.004793317,0.008193159,0.007666531,0.8864856,0.000211251],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.03246432,0.01854998,0.1038551,0.06136533,0.00898831,0.01801128,0.3242432,0.02187622,0.4106461],"genre_scores_gemma":[0.2173051,0.02736649,0.1752804,0.07696211,0.006662626,0.01752878,0.367134,0.002482402,0.1092781],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02633298,"threshold_uncertainty_score":0.1194932,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1986483795","doi":"10.1007/s40290-015-0090-x","title":"Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine","year":2015,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nordic Life Science Pipeline (Canada)","funders":"","keywords":"Big data; Medicine; Business; Pharmacology; Computer science; Data mining","authors":[{"name":"Peter Tormay","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3911000808631966,"gpt":0.4883167418636923,"spread":0.09721666100049575,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05427015,0.001832857,0.002144999,0.006228354,0.003402642,0.02230996,0.006219173,0.009735925,0.008487879],"category_scores_gemma":[0.05749935,0.001484457,0.002011797,0.009135667,0.008012653,0.04285723,0.02131755,0.01189529,0.007033562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003849925,"about_ca_system_score_gemma":0.01701786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002437179,"about_ca_topic_score_gemma":0.002403274,"domain_scores_codex":[0.9803078,0.008369987,0.001230344,0.001399429,0.007333781,0.00135875],"domain_scores_gemma":[0.9448499,0.02528062,0.002686688,0.008714805,0.01083144,0.007636594],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0003323246,0.0003470864,0.00410364,0.001951445,0.000324186,0.0005093704,0.0009494842,0.008913415,0.00255496,0.4841311,0.2060362,0.2898468],"study_design_scores_gemma":[0.00009442326,0.00009811407,0.0008157457,0.001216036,0.00005812346,0.0001364264,0.0009911325,0.01095689,0.001663792,0.6152589,0.3686148,0.00009556672],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.00995212,0.05206142,0.2030255,0.672869,0.012015,0.0005285871,0.001942248,0.001957622,0.04564833],"genre_scores_gemma":[0.2061625,0.1122298,0.5221052,0.1079832,0.02374673,0.001390564,0.005047191,0.001604932,0.01972982],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.05427015,"threshold_uncertainty_score":0.2870114,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2287309625","doi":"10.1007/s40290-015-0124-4","title":"The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore","year":2015,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Health Canada","keywords":"Excellence; Transparency (behavior); Certification; Agency (philosophy); Business; Health care; Timeline; Medicine; Product (mathematics); Public relations; Political science; Sociology","authors":[{"name":"Hajed Hashan","is_ca":false},{"name":"Ibrahim A. Aljuffali","is_ca":false},{"name":"Prisha Patel","is_ca":false},{"name":"Stuart Walker","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3241643169139876,"gpt":0.4996421192241557,"spread":0.1754778023101681,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05999889,0.0002898031,0.0003789638,0.005591927,0.00388173,0.005646359,0.001369479,0.001077917,0.002443745],"category_scores_gemma":[0.07586373,0.0004428528,0.0005587017,0.004988616,0.002729187,0.001868734,0.003203219,0.0007975891,0.0003700271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03106868,"about_ca_system_score_gemma":0.07886623,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4074198,"about_ca_topic_score_gemma":0.4435337,"domain_scores_codex":[0.9467258,0.02031448,0.005161386,0.001680934,0.0236323,0.00248501],"domain_scores_gemma":[0.8005478,0.04716148,0.03900472,0.004650647,0.09153876,0.01709664],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002231519,0.0006685221,0.6718159,0.002544838,0.0002676689,0.001149648,0.06209617,0.0006806941,0.003373783,0.003621701,0.008292195,0.2432573],"study_design_scores_gemma":[0.000169276,0.001412504,0.8835233,0.0009021416,0.0001592024,0.000802446,0.0512088,0.001249016,0.001890027,0.0001453686,0.05836747,0.0001702919],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9728466,0.005681028,0.0005660523,0.004779667,0.00008667697,0.0008967932,0.0004391717,0.00008404202,0.01462005],"genre_scores_gemma":[0.9924706,0.002317908,0.001600796,0.0008290001,0.00002216726,0.0001268748,0.0002433398,0.00002281156,0.0023665],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9400011,"threshold_uncertainty_score":0.8100967,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308697730","doi":"10.1007/s40290-022-00447-7","title":"The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes","year":2022,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Thornhill Medical (Canada)","funders":"","keywords":"Clinical trial; Medicine; Cannabis; Synthetic cannabinoids; Randomized controlled trial; Drug development; Drug; Cannabinoid; Pharmacology; Psychiatry; Internal medicine","authors":[{"name":"Farhang Modaresi","is_ca":true},{"name":"Kaivan Talachian","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6472075699016272,"gpt":0.6247242841693867,"spread":0.02248328573224045,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01191055,0.001436212,0.006668622,0.006815267,0.0004009194,0.003426247,0.00211242,0.002294376,0.004804586],"category_scores_gemma":[0.03392566,0.0008489839,0.004340117,0.008671049,0.00119657,0.002726169,0.001241395,0.00208543,0.000673905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002648761,"about_ca_system_score_gemma":0.00614545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001895027,"about_ca_topic_score_gemma":0.007111621,"domain_scores_codex":[0.9925296,0.002076821,0.002841917,0.0008621477,0.001500114,0.0001893877],"domain_scores_gemma":[0.9506726,0.03854028,0.006967385,0.0004809381,0.002847175,0.000491594],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001414708,0.00008030288,0.0009130568,0.5065351,0.004748704,0.0001730349,0.0001487954,0.0004068603,0.001404561,0.001640559,0.005970837,0.4765636],"study_design_scores_gemma":[0.001339208,0.001589553,0.01074498,0.5123864,0.04755596,0.00260782,0.0004370462,0.0003957663,0.0015256,0.003580919,0.4176713,0.0001655097],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001491702,0.9991785,0.0001125171,0.0001639378,0.00004400044,0.00004765979,0.0001034612,0.000003041806,0.0001976672],"genre_scores_gemma":[0.002431725,0.9959911,0.000691238,0.000486642,0.00007840109,0.00008398809,0.0001236161,0.000004783186,0.0001085574],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01191055,"threshold_uncertainty_score":0.06298983,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W103748181","doi":"10.1007/bf03256813","title":"The Changing Face of Direct-to-Consumer Print Advertising","year":2010,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"University of Georgia","keywords":"Advertising; Order (exchange); Quarter (Canadian coin); Business; Balance (ability); Over-the-counter; Content analysis; Medical prescription; Medicine","authors":[{"name":"Wendy Macias","is_ca":false},{"name":"Liza Stavchansky Lewis","is_ca":false},{"name":"Tae Hyun Baek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3249485468030795,"gpt":0.5636868487637329,"spread":0.2387383019606534,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006934174,0.00043927,0.0005714527,0.002167834,0.004347648,0.02100291,0.001788012,0.01100637,0.05040647],"category_scores_gemma":[0.02573117,0.0004764127,0.0004925933,0.001732713,0.008100485,0.01957467,0.003114623,0.008998822,0.007123378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005220765,"about_ca_system_score_gemma":0.002344605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005921605,"about_ca_topic_score_gemma":0.01057933,"domain_scores_codex":[0.993693,0.001460345,0.0002194468,0.0009437124,0.003054891,0.0006286012],"domain_scores_gemma":[0.9703081,0.01733821,0.002219322,0.001297456,0.005418147,0.00341876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","study_design_scores_codex":[0.0003239117,0.0002648696,0.009936946,0.0004808697,0.00003768234,0.001750309,0.01102405,0.0005603699,0.002800298,0.4351912,0.2772205,0.2604091],"study_design_scores_gemma":[0.00003700665,0.00009603135,0.01554614,0.0004648372,0.00002201375,0.002062286,0.01391747,0.001013606,0.0008145129,0.09006475,0.8758327,0.0001285524],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.05654377,0.01523554,0.003486708,0.5499229,0.006212087,0.00003459562,0.0003643418,0.0002718267,0.3679283],"genre_scores_gemma":[0.7551663,0.01456778,0.003165133,0.1243099,0.0239168,0.00004993862,0.0001949596,0.0004666528,0.07816254],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05040647,"threshold_uncertainty_score":0.1686264,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2567239969","doi":"10.1007/s40290-016-0172-4","title":"The Jordan Food and Drug Administration: Comparison of its Registration Process with Australia, Canada, Saudi Arabia and Singapore","year":2016,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Health Canada","keywords":"Timeline; Food and drug administration; Regulatory affairs; Agency (philosophy); Medicine; Certificate; Business; Medical education; Political science; Public administration; Environmental health; Computer science; Sociology","authors":[{"name":"Wesal Salem Al Haqaish","is_ca":false},{"name":"Hayel Obeidat","is_ca":false},{"name":"Prisha Patel","is_ca":false},{"name":"Stuart Walker","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1570323107562076,"gpt":0.4712236755776073,"spread":0.3141913648213998,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02743171,0.0002965867,0.0002799055,0.003414507,0.002445966,0.005149028,0.001281813,0.0008885827,0.005542532],"category_scores_gemma":[0.04180086,0.0003203108,0.0005011839,0.005893929,0.001450824,0.001588114,0.001854048,0.0009029429,0.001364337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02683777,"about_ca_system_score_gemma":0.09718445,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6437771,"about_ca_topic_score_gemma":0.6721751,"domain_scores_codex":[0.9712742,0.006966793,0.002007429,0.001331038,0.01629326,0.002127249],"domain_scores_gemma":[0.9298582,0.009508683,0.008857423,0.001754627,0.0427507,0.007270477],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001607761,0.0004711575,0.4263487,0.001772704,0.0001909232,0.001356772,0.01569878,0.00100176,0.002666732,0.01625733,0.06590999,0.4667175],"study_design_scores_gemma":[0.0001711646,0.0007615577,0.6933712,0.0007593171,0.00009586459,0.001120224,0.01167966,0.001651094,0.002366721,0.0004110484,0.2874828,0.0001293235],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.671095,0.02629941,0.003296691,0.03424976,0.0006024882,0.002809174,0.003907763,0.0005979202,0.2571417],"genre_scores_gemma":[0.9397534,0.01043992,0.005643891,0.006710508,0.0001375381,0.0004048767,0.002506017,0.0001627234,0.03424118],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3562229,"threshold_uncertainty_score":0.7166415,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W53859789","doi":"10.1007/bf03256848","title":"A Proposed Framework for Formulary Listing in Low-Income Countries","year":2011,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Formulary; Listing (finance); Psychological intervention; High income countries; Actuarial science; Medicine; Health care; Developing country; Business; Public economics; Family medicine; Economic growth; Economics; Finance; Nursing","authors":[{"name":"Vakaramoko Diaby","is_ca":true},{"name":"Claudine Laurier","is_ca":true},{"name":"Jean Lachaîne","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5612886048884482,"gpt":0.5196973706371593,"spread":0.04159123425128897,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006943776,0.0008000595,0.0013445,0.002967938,0.00311687,0.01156745,0.003111399,0.005470992,0.0231618],"category_scores_gemma":[0.01464516,0.0007754202,0.001449809,0.004393484,0.003484105,0.007673413,0.00307145,0.002945594,0.001717162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004763507,"about_ca_system_score_gemma":0.005987929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02170636,"about_ca_topic_score_gemma":0.0227262,"domain_scores_codex":[0.9945508,0.002754831,0.0003440372,0.0009256092,0.000655733,0.0007689401],"domain_scores_gemma":[0.9905014,0.004731243,0.001099539,0.000724444,0.002333855,0.0006094063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.00001040373,0.00002851429,0.0007375845,0.00003223813,0.00001390736,0.000131609,0.0001290927,0.007126411,0.00004454092,0.9815123,0.004227898,0.006005439],"study_design_scores_gemma":[0.00008583683,0.00005051634,0.001401234,0.000155567,0.00004476742,0.0002280269,0.0005892203,0.06242144,0.0001930482,0.91092,0.023846,0.00006438011],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.04199883,0.00163677,0.7304707,0.0396466,0.0004490179,0.0007728308,0.002704459,0.0006668085,0.1816539],"genre_scores_gemma":[0.6911151,0.001102611,0.276151,0.002274157,0.0005633811,0.0007939577,0.001142241,0.00009536358,0.02676214],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.0231618,"threshold_uncertainty_score":0.07748395,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400475270","doi":"10.1007/s40290-024-00529-8","title":"Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials","year":2024,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Generalizability theory; Inclusion (mineral); Clinical trial; Diversity (politics); Equity (law); Medicine; Disease; Relevance (law); Management science; Psychology; Pathology; Political science","authors":[{"name":"Gareth Baynam","is_ca":false},{"name":"Simeón Baker","is_ca":true},{"name":"Charles A. Steward","is_ca":false},{"name":"Marshall Summar","is_ca":false},{"name":"Meghan C. Halley","is_ca":false},{"name":"Anne Pariser","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4169885344615545,"gpt":0.6002199609442508,"spread":0.1832314264826963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00930022,0.0006341003,0.002641083,0.002452642,0.0003025794,0.002588673,0.00139551,0.00245618,0.005415394],"category_scores_gemma":[0.01352889,0.0003284806,0.001000315,0.002581166,0.001226118,0.002249727,0.001863413,0.003019074,0.0007854698],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001913,"about_ca_system_score_gemma":0.00329369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001339448,"about_ca_topic_score_gemma":0.004193716,"domain_scores_codex":[0.9971305,0.001382884,0.0003444302,0.0002604187,0.0007310353,0.0001507442],"domain_scores_gemma":[0.986892,0.0110827,0.0009340582,0.0001332635,0.0006869873,0.0002709643],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001084461,0.00003807915,0.0001890918,0.02544892,0.000284018,0.00008593004,0.00007175609,0.0002757398,0.000191915,0.01261174,0.01826396,0.9424304],"study_design_scores_gemma":[0.0003174305,0.0001812973,0.002348413,0.05125508,0.001018286,0.001001138,0.0001752247,0.0003098839,0.0002576546,0.02420286,0.9188799,0.00005279123],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004773373,0.9979981,0.0001447477,0.001189184,0.0001232831,0.000006315251,0.00001106249,0.000004162852,0.0004754482],"genre_scores_gemma":[0.001351383,0.9965848,0.0003431503,0.001123916,0.0003799266,0.00001831199,0.0000169476,0.00000187819,0.0001797094],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9906998,"threshold_uncertainty_score":0.04918486,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4317391044","doi":"10.1007/s40290-022-00459-3","title":"Digital Therapies (DTx) as New Tools within Physicians’ Therapeutic Arsenal: Key Observations to Support their Effective and Responsible Development and Use","year":2023,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":6,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Cegep Edouard Montpetit; Université de Montréal; Simon Fraser University","funders":"","keywords":"Psychological intervention; Intervention (counseling); Digital health; Engineering ethics; Medicine; Business; Risk analysis (engineering); Public relations; Political science; Health care; Engineering; Nursing","authors":[{"name":"Jean‐Christophe Bélisle‐Pipon","is_ca":true},{"name":"Pierre‐Marie David","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2372385690793367,"gpt":0.458602792905748,"spread":0.2213642238264113,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008671271,0.0003978957,0.0003258966,0.0009882814,0.001683527,0.007862474,0.0008541694,0.002072743,0.0085609],"category_scores_gemma":[0.01402068,0.0002019328,0.0002792903,0.0007612798,0.008225059,0.006307663,0.004137306,0.003611879,0.001178225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002192182,"about_ca_system_score_gemma":0.006931568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001005102,"about_ca_topic_score_gemma":0.001772693,"domain_scores_codex":[0.9941018,0.003373719,0.0002439947,0.0004617551,0.001383263,0.0004353491],"domain_scores_gemma":[0.9797407,0.01380795,0.002007991,0.001362666,0.00145652,0.001624063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0002291065,0.0005553921,0.01073811,0.0019272,0.00005107393,0.0005608866,0.01934095,0.0002583845,0.003674496,0.5500088,0.01983858,0.392817],"study_design_scores_gemma":[0.0001662806,0.0006285298,0.04240796,0.005585435,0.0001218438,0.003379946,0.03481118,0.001365808,0.006161955,0.2810603,0.6242164,0.0000944392],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"other","genre_gemma":"commentary","genre_scores_codex":[0.1430597,0.1035557,0.05717669,0.2061409,0.003264828,0.0007097835,0.0003081416,0.0003893271,0.485395],"genre_scores_gemma":[0.9112709,0.03250244,0.03096183,0.01271213,0.001248988,0.0002664883,0.0000602188,0.00007656987,0.01090049],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.008671271,"threshold_uncertainty_score":0.04585862,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4372333015","doi":"10.1007/s40290-023-00474-y","title":"Embedding Patient-Centricity by Collaborating with Patients to Transform the Rare Disease Ecosystem","year":2023,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"Alexion Pharmaceuticals; AstraZeneca","keywords":"Embedding; Medicine; Disease; Ecosystem; Pharmacotherapy; Intensive care medicine; Internal medicine; Computer science; Biology; Ecology; Artificial intelligence","authors":[{"name":"Rohita Sharma","is_ca":true},{"name":"Sumaira Ahmed","is_ca":false},{"name":"Judy Campagnari","is_ca":false},{"name":"Wendi Huff","is_ca":false},{"name":"Lelainia Lloyd","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0118236033157068,"gpt":0.2962372390432417,"spread":0.2844136357275349,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02208121,0.001068952,0.0004188278,0.001066943,0.006198915,0.01391446,0.002462197,0.004016933,0.00984029],"category_scores_gemma":[0.02176026,0.0005838884,0.00137408,0.0004691862,0.01417629,0.01200157,0.02845191,0.008209002,0.00250004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003516712,"about_ca_system_score_gemma":0.0101134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009433846,"about_ca_topic_score_gemma":0.001843328,"domain_scores_codex":[0.9569173,0.03717261,0.0005737509,0.001387341,0.001914249,0.002034633],"domain_scores_gemma":[0.9789508,0.01057091,0.001292281,0.00214884,0.001189816,0.005847226],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"qualitative","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003085725,0.001272051,0.01732334,0.001468152,0.0002302851,0.003943695,0.4270319,0.007337238,0.009004645,0.284337,0.0505944,0.1971487],"study_design_scores_gemma":[0.000170826,0.0009207437,0.002172027,0.001602395,0.0001201276,0.003399516,0.1617902,0.006459641,0.004314102,0.1862293,0.632605,0.0002160903],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.229723,0.004124429,0.331609,0.2298482,0.003388407,0.001178516,0.0002653512,0.001930207,0.1979329],"genre_scores_gemma":[0.8788314,0.001788986,0.09099474,0.01551121,0.0004377743,0.0006836917,0.0001668887,0.0004093588,0.01117593],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02208121,"threshold_uncertainty_score":0.116778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4377221230","doi":"10.1007/s40290-023-00478-8","title":"Current Status and Challenges of Pharmacovigilance of Traditional Medicines in French-Speaking West African (UEMOA) Countries","year":2023,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"Fondation Pierre Fabre","keywords":"Pharmacovigilance; Medicine; Pharmacotherapy; Traditional medicine; Pharmacology; Drug; Psychiatry","authors":[{"name":"Kampadilemba Ouoba","is_ca":false},{"name":"Hélène Lehmann","is_ca":false},{"name":"Arsène Zongo","is_ca":true},{"name":"Jean-Yves Pabst","is_ca":false},{"name":"Rasmané Semdé","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2678028493135785,"gpt":0.4421318686843909,"spread":0.1743290193708124,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02104118,0.0003653075,0.00103721,0.003677983,0.0007432866,0.005262936,0.00200368,0.001513674,0.002714325],"category_scores_gemma":[0.02635928,0.0002128261,0.0007476941,0.004379997,0.001300844,0.002121359,0.001459299,0.001086398,0.0002435426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0051215,"about_ca_system_score_gemma":0.01273015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04826011,"about_ca_topic_score_gemma":0.03465642,"domain_scores_codex":[0.9920372,0.003045048,0.001463597,0.0008142755,0.001800509,0.0008393878],"domain_scores_gemma":[0.9586965,0.0185553,0.01013967,0.0007215564,0.009626647,0.002260332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006312486,0.0002407404,0.3539158,0.008705881,0.0006952723,0.001508683,0.004927619,0.001036325,0.001699627,0.01525241,0.02266086,0.5887255],"study_design_scores_gemma":[0.0001798645,0.0009087116,0.6024799,0.0190813,0.00170851,0.005936788,0.0238265,0.004815086,0.002418551,0.009311237,0.3290873,0.000246345],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2225944,0.5540546,0.00388339,0.1985641,0.000793344,0.0000804197,0.002695777,0.0003354854,0.01699844],"genre_scores_gemma":[0.8610009,0.1095606,0.007047787,0.01909596,0.001161781,0.00005684228,0.001322483,0.00004205745,0.0007115474],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.04826011,"threshold_uncertainty_score":0.1112778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3121676279","doi":"10.1007/s40290-020-00370-9","title":"Drug Advertising Violations: A Longitudinal Trend Analysis of FDA Enforcement Letters from 2005 to 2019","year":2021,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Work & Health; Public Health Ontario; McMaster University; University of Toronto","funders":"","keywords":"Enforcement; Revenue; Promotion (chess); Advertising; Business; Medical prescription; Food and drug administration; Prescription drug; Medicine; Marketing; Accounting; Environmental health; Pharmacology; Political science; Law","authors":[{"name":"Katherine Zagrodney","is_ca":true},{"name":"Natasha Y. Sheikhan","is_ca":true},{"name":"Ashlyn Pinto","is_ca":true},{"name":"Tania Sheikhan","is_ca":false},{"name":"Theodore J. Witek","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3513951824707327,"gpt":0.5601475269582138,"spread":0.2087523444874811,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001862848,0.0002701449,0.0003483851,0.003791072,0.0006654778,0.001956411,0.0009808157,0.001301568,0.003826108],"category_scores_gemma":[0.008049319,0.0004434112,0.0009129986,0.006388384,0.0003534066,0.002022804,0.00126414,0.001514773,0.001409688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001649275,"about_ca_system_score_gemma":0.002018644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.09051014,"about_ca_topic_score_gemma":0.1211721,"domain_scores_codex":[0.9976031,0.0003516002,0.0004588431,0.0004778975,0.0004873857,0.000621202],"domain_scores_gemma":[0.9838803,0.00155102,0.01063823,0.0005115733,0.002589351,0.0008294569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001306036,0.00008115871,0.9965411,0.00001621384,0.00007441983,0.00004631442,0.0001931755,0.00006463247,0.00004015774,0.00004089491,0.0009300089,0.001841275],"study_design_scores_gemma":[0.000002797753,0.00005569201,0.9979361,0.00001693609,0.00002547841,0.00008162357,0.0006571247,0.0003414801,0.00003503131,0.00001561417,0.0008246854,0.000007501999],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986126,0.0005046699,0.0001440427,0.0004985525,0.00002551412,0.00002261424,0.0107729,0.00002561637,0.001880204],"genre_scores_gemma":[0.9880602,0.0003084352,0.0001206812,0.0001603185,0.00002456138,0.00002979771,0.009553568,0.0000136551,0.001728731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09051014,"threshold_uncertainty_score":0.1799666,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2941706251","doi":"10.1007/s40290-019-00278-z","title":"Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures","year":2019,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Bayer (Canada)","funders":"Bayer","keywords":"Aflibercept; Medicine; Key (lock); Risk analysis (engineering); Intensive care medicine; Risk assessment; Surgery; Computer science; Chemotherapy","authors":[{"name":"L. Zografos","is_ca":false},{"name":"Elizabeth Andrews","is_ca":false},{"name":"Dan L. Wolin","is_ca":false},{"name":"Brian Calingaert","is_ca":false},{"name":"Eric Davenport","is_ca":false},{"name":"Kelly Hollis","is_ca":false},{"name":"Nada Djokanovic","is_ca":true},{"name":"Vito S. Racanelli","is_ca":true},{"name":"Paul Petraro","is_ca":false},{"name":"Zdravko P. Vassilev","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08479523333586769,"gpt":0.3955978097442033,"spread":0.3108025764083356,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00595187,0.0003255522,0.000478053,0.001555047,0.001713733,0.0008491393,0.001169127,0.0006281557,0.003683115],"category_scores_gemma":[0.03212691,0.0003344109,0.0006524881,0.002101461,0.0008666872,0.0006845474,0.000866111,0.0006896037,0.0002849808],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02614484,"about_ca_system_score_gemma":0.04563308,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8915033,"about_ca_topic_score_gemma":0.9015791,"domain_scores_codex":[0.9933014,0.001205332,0.0006526954,0.0003654058,0.003853962,0.0006212243],"domain_scores_gemma":[0.9620465,0.007469537,0.007724647,0.0005091747,0.01766677,0.00458337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001115578,0.0009749004,0.945956,0.0005623379,0.0001382895,0.0001014593,0.002420848,0.000509189,0.0003515713,0.0001138292,0.002772056,0.04498396],"study_design_scores_gemma":[0.0001245064,0.0007858763,0.9945149,0.0001127539,0.00007250638,0.00005281884,0.001159284,0.001157069,0.0002493171,0.0000240124,0.001723255,0.00002381233],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852822,0.001093458,0.0004116174,0.001336738,0.00002585741,0.0009716828,0.001470784,0.00005112824,0.00935639],"genre_scores_gemma":[0.9965801,0.0005005241,0.001150162,0.0002171449,0.00001047889,0.0001608836,0.0005146381,0.000004523212,0.0008616261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9738551,"threshold_uncertainty_score":0.2182712,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3042380614","doi":"10.1007/s40290-020-00345-w","title":"Using Data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for Drug Safety Research: A Feasibility Study","year":2020,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Université du Québec à Trois-Rivières","funders":"","keywords":"Pharmacovigilance; Medicine; Drug reaction; Postmarketing surveillance; Adverse drug reaction; Data quality; Pharmacoepidemiology; Descriptive statistics; Drug; Pharmacology; Database; Adverse effect; Business; Marketing; Computer science; Statistics","authors":[{"name":"Samuel Akinola","is_ca":false},{"name":"Carolina Galli da Silveira","is_ca":false},{"name":"Sonia Corbin","is_ca":true},{"name":"Maude Lavallée","is_ca":true},{"name":"Magalie Thibault","is_ca":true},{"name":"Jennifer Midiani Gonella","is_ca":false},{"name":"Fernanda Raphael Escobar Gimenes","is_ca":false},{"name":"Jacinthe Leclerc","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7319876051940398,"gpt":0.5953530109512966,"spread":0.1366345942427433,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02586521,0.00141583,0.001300254,0.006346297,0.003584197,0.00335978,0.00294793,0.001662024,0.003483553],"category_scores_gemma":[0.08209559,0.0007874502,0.002200712,0.01258759,0.001336562,0.001763906,0.002321676,0.001382933,0.0009520893],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03433157,"about_ca_system_score_gemma":0.0916106,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9469754,"about_ca_topic_score_gemma":0.9448605,"domain_scores_codex":[0.9646677,0.009344156,0.003483208,0.002612627,0.01727379,0.002618571],"domain_scores_gemma":[0.9030915,0.02232748,0.01124909,0.006127276,0.05382749,0.003377252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002626122,0.001744165,0.9502202,0.0009279409,0.0008890032,0.0003578792,0.002278506,0.00117544,0.0008029054,0.001014685,0.007832881,0.03013028],"study_design_scores_gemma":[0.000905734,0.0012825,0.9796718,0.0002258967,0.0007492065,0.0002694034,0.001601052,0.003068893,0.0007535223,0.0001933098,0.01115336,0.0001253033],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9168526,0.00124418,0.004978793,0.001207318,0.00008686779,0.01302714,0.0500254,0.0001595088,0.01241814],"genre_scores_gemma":[0.9441758,0.0008431147,0.01651277,0.001632034,0.00008854985,0.005295817,0.02905522,0.00007354173,0.002323108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9656684,"threshold_uncertainty_score":0.2490941,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3203314040","doi":"10.1007/s40290-021-00402-y","title":"How the Global COVID-19 Pandemic Brought Drug and Vaccine Development into the Public Mainstream","year":2021,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Ontario","funders":"","keywords":"Pandemic; Drug development; Mainstream; Pharmacovigilance; Public health; Medicine; Coronavirus disease 2019 (COVID-19); Pharmaceutical industry; Procurement; Business; Public relations; Political science; Drug; Economic growth; Pharmacology; Disease; Infectious disease (medical specialty); Marketing","authors":[{"name":"Theodore J. Witek","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2416920572438608,"gpt":0.4934767466812031,"spread":0.2517846894373423,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002000942,0.0008715222,0.001889151,0.002681067,0.0003930227,0.002567567,0.0008957253,0.003032807,0.007699566],"category_scores_gemma":[0.003366684,0.0004099853,0.001068598,0.003026938,0.0008077618,0.003261364,0.001127331,0.00433258,0.002031509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002363694,"about_ca_system_score_gemma":0.005702421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004907985,"about_ca_topic_score_gemma":0.01172612,"domain_scores_codex":[0.999373,0.0001889373,0.00007020437,0.00009063243,0.0001937375,0.00008354342],"domain_scores_gemma":[0.9979271,0.001294609,0.0001886808,0.00003330881,0.0004343963,0.0001218509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001763729,0.00006917051,0.0001334032,0.03271475,0.0002719048,0.0001237327,0.0001163024,0.0005164967,0.0008321906,0.0175125,0.06911726,0.8784159],"study_design_scores_gemma":[0.00005224409,0.00008412401,0.000485474,0.01656217,0.0002507516,0.000229082,0.0001075744,0.00008336482,0.0001332584,0.004806938,0.9771828,0.00002221664],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003953554,0.9971421,0.00004112913,0.001757987,0.0003059197,0.000002920821,0.00002532442,0.000003808299,0.0006812643],"genre_scores_gemma":[0.0004666421,0.997577,0.00008864233,0.001268414,0.00022773,0.000005333269,0.00002448199,0.00000127305,0.0003404218],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007699566,"threshold_uncertainty_score":0.02575767,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W48989372","doi":"10.1007/bf03256677","title":"Drug Approval Times and User Fees","year":2008,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"York University; University of Toronto; University Health Network","funders":"","keywords":"Government (linguistics); Business; Agency (philosophy); Approved drug; Drug; Payment; User fee; Finance; Drug approval; Resource (disambiguation); Orphan drug; Public economics; Medicine; Pharmacology; Economics","authors":[{"name":"Joel Lexchin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.109312447388494,"gpt":0.3302034876115756,"spread":0.2208910402230816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003847579,0.0004828247,0.0009231283,0.003195083,0.001004812,0.006081074,0.0008000035,0.002982151,0.03827295],"category_scores_gemma":[0.08799577,0.0005980243,0.001203726,0.003392283,0.00115521,0.005577478,0.001001388,0.004088372,0.003143652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002867587,"about_ca_system_score_gemma":0.001479195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005491485,"about_ca_topic_score_gemma":0.004999316,"domain_scores_codex":[0.9956949,0.001537376,0.0004173765,0.0003495769,0.001036448,0.0009643239],"domain_scores_gemma":[0.8832746,0.08329359,0.01800349,0.003635758,0.006812932,0.004979595],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","study_design_scores_codex":[0.006034427,0.0007393073,0.187548,0.0007243319,0.0006484775,0.001982574,0.0014343,0.04054593,0.002204601,0.5145289,0.05349974,0.1901094],"study_design_scores_gemma":[0.0006675621,0.001083604,0.3363985,0.0005071425,0.001266214,0.01087129,0.002501895,0.1105497,0.004361244,0.424262,0.1071483,0.000382568],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6781485,0.02185206,0.02177855,0.02218903,0.0006435857,0.0001216311,0.007607886,0.0007164768,0.2469424],"genre_scores_gemma":[0.9751414,0.00150231,0.0006193426,0.0004138546,0.0003004635,0.00001838369,0.0006914424,0.00008734085,0.02122547],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9961524,"threshold_uncertainty_score":0.1280358,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980001858","doi":"10.1007/bf03256800","title":"Pharmaceutical Medicine in Switzerland","year":2010,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Specialty; Pharmaceutical industry; Medical education; Alternative medicine; Medicine; Pharmacy; Work (physics); Family medicine; Pharmacology; Engineering","authors":[{"name":"Martin Traber","is_ca":true},{"name":"Beat Althaus","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1196604684812541,"gpt":0.4748456926701231,"spread":0.3551852241888689,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008346531,0.0004213061,0.0002187562,0.002354981,0.001836916,0.002962403,0.0001888464,0.001707246,0.04436181],"category_scores_gemma":[0.001459151,0.0001579035,0.000246456,0.001662889,0.001337291,0.001115016,0.001958912,0.001187551,0.007274108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002605903,"about_ca_system_score_gemma":0.004421261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01294715,"about_ca_topic_score_gemma":0.01728519,"domain_scores_codex":[0.999025,0.0002877223,0.0000636967,0.0001326039,0.0002249105,0.0002659766],"domain_scores_gemma":[0.9988589,0.0002833836,0.0001808808,0.00007657493,0.0001955008,0.0004047281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005168415,0.0003135879,0.0364181,0.001206423,0.00006911372,0.003704638,0.003775476,0.001280445,0.0118153,0.3442144,0.2305093,0.3661764],"study_design_scores_gemma":[0.000070243,0.000188976,0.131974,0.0005077782,0.00001920516,0.0013156,0.001377827,0.0005113576,0.001641265,0.005574724,0.8567882,0.00003085928],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.1180812,0.08374888,0.00120247,0.07139847,0.003825261,0.00008094434,0.001779964,0.0006124552,0.7192703],"genre_scores_gemma":[0.720084,0.0175462,0.001119353,0.003191598,0.001673146,0.0000692657,0.0007138559,0.0000836518,0.2555189],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.04436181,"threshold_uncertainty_score":0.148405,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2987745860","doi":"10.1007/s40290-019-00306-y","title":"Current Landscape of Late-Phase Clinical Trials for Alzheimer’s Disease: Comparing Regional Variation Between Subjects in Japan and North America","year":2019,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute on Aging; Canadian Institutes of Health Research","keywords":"Clinical trial; Medicine; Clinical endpoint; Population; Observational study; Clinical Dementia Rating; Disease; Dementia; Internal medicine; Environmental health","authors":[{"name":"Masashi Kikuchi","is_ca":false},{"name":"Noriaki Adachi","is_ca":false},{"name":"Naoki Matsumaru","is_ca":false},{"name":"Katsura Tsukamoto","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4100726253645589,"gpt":0.5541037621333915,"spread":0.1440311367688327,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09982634,0.000439303,0.002485195,0.003110279,0.001190321,0.004344805,0.001791432,0.00104709,0.001742209],"category_scores_gemma":[0.1170615,0.000556285,0.001431463,0.005578282,0.002553905,0.002703871,0.001672302,0.001260802,0.0002727307],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003822885,"about_ca_system_score_gemma":0.009141047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01963438,"about_ca_topic_score_gemma":0.0403148,"domain_scores_codex":[0.9290491,0.04928214,0.01039867,0.005230016,0.004285021,0.001755109],"domain_scores_gemma":[0.7951075,0.1030716,0.04808699,0.008290778,0.03605809,0.00938509],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007158762,0.0005048073,0.7601483,0.003567083,0.004125807,0.0001619334,0.002013274,0.0009990003,0.001785193,0.004063786,0.01012743,0.2053447],"study_design_scores_gemma":[0.0008580546,0.001548299,0.9705372,0.001633806,0.002210426,0.0003001798,0.002214591,0.0009558734,0.0003586935,0.002731649,0.01657993,0.00007129125],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6414849,0.2765665,0.008179152,0.0533722,0.001015433,0.0006060989,0.003790545,0.0001410288,0.0148442],"genre_scores_gemma":[0.9675502,0.01566877,0.00498135,0.008524361,0.0008320548,0.0003632292,0.001622147,0.00006953414,0.0003883203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9001737,"threshold_uncertainty_score":0.5279384,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2615558757","doi":"10.1007/s40290-017-0191-9","title":"Myths and Realities About Why Prescription Drug Prices in the United States Are So High","year":2017,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"York University; University of Toronto; University Health Network","funders":"","keywords":"Medical prescription; Drug; Medicine; Pharmacotherapy; Mythology; Drug prices; Environmental health; Political science; Family medicine; Traditional medicine; Pharmacology; Psychiatry; Public economics; Economics; History","authors":[{"name":"Joel Lexchin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1102260002497919,"gpt":0.3562483066323625,"spread":0.2460223063825706,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00761616,0.0002255376,0.0003539344,0.001294337,0.001280138,0.005231169,0.0009034011,0.005110666,0.00384537],"category_scores_gemma":[0.0541773,0.0003715949,0.0003991046,0.001852563,0.01003707,0.005961024,0.001300547,0.007519088,0.0004285072],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003348547,"about_ca_system_score_gemma":0.003232973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01017512,"about_ca_topic_score_gemma":0.009218154,"domain_scores_codex":[0.9962484,0.00135103,0.0002161951,0.000706834,0.0009385329,0.0005389438],"domain_scores_gemma":[0.9555387,0.02708247,0.01017587,0.00114609,0.003820818,0.002236068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","study_design_scores_codex":[0.0006176991,0.0003080916,0.1679545,0.0008419387,0.0006881356,0.0008238435,0.01072615,0.004330985,0.0006417256,0.453825,0.270098,0.08914399],"study_design_scores_gemma":[0.0001809946,0.00007666461,0.1488432,0.001434292,0.0001799379,0.0005746735,0.02454247,0.004852338,0.001452744,0.6838256,0.1338196,0.0002175453],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.06899132,0.008958888,0.001269558,0.9042188,0.00125394,0.000007529218,0.0004162306,0.00002674614,0.01485695],"genre_scores_gemma":[0.9137241,0.006913597,0.0005386823,0.07516855,0.002525428,0.0000159544,0.0001223818,0.0000284572,0.0009628999],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01017512,"threshold_uncertainty_score":0.04027861,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2342279036","doi":"10.1007/s40290-016-0142-x","title":"Content Related to Older Adults in Canadian Innovator–Drug Product Monographs: An Exploratory Analysis","year":2016,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Innovator; Geriatrics; Notice; Product (mathematics); Population; Gerontology; Family medicine; Computer science; Environmental health; Psychiatry","authors":[{"name":"Hazal E. Babadagli","is_ca":true},{"name":"M. Ken Cor","is_ca":true},{"name":"Cheryl A Sadowski","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1531829746538198,"gpt":0.4233277601544785,"spread":0.2701447855006587,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003714576,0.0003057142,0.0005449872,0.009879291,0.002381069,0.002527642,0.001047032,0.0008647265,0.003235942],"category_scores_gemma":[0.02867872,0.0002228522,0.0007866361,0.0113517,0.0009999969,0.001068338,0.002256234,0.00108065,0.0002414629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02245257,"about_ca_system_score_gemma":0.03134236,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8102018,"about_ca_topic_score_gemma":0.8716773,"domain_scores_codex":[0.9965792,0.000419563,0.0004276864,0.0002534454,0.001629476,0.0006906081],"domain_scores_gemma":[0.961535,0.01333556,0.010545,0.0004897527,0.01026947,0.00382533],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003228874,0.0002034224,0.9641085,0.0003697289,0.0001091023,0.0001466227,0.01939849,0.00004256327,0.0003009305,0.0001757781,0.0017583,0.01306365],"study_design_scores_gemma":[0.000008105984,0.00004524493,0.986124,0.0001110457,0.00006357592,0.00004056666,0.01155199,0.00007002855,0.00006664593,0.00002136926,0.00188671,0.00001057214],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920787,0.0007088254,0.00007264261,0.0002684816,0.000009987154,0.000208672,0.00410428,0.00000791066,0.002540557],"genre_scores_gemma":[0.9931693,0.000835938,0.0005544378,0.0004085042,0.00003415497,0.0002283636,0.003395304,0.00001488848,0.00135906],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1897982,"threshold_uncertainty_score":0.3818319,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4416741600","doi":"10.1093/med/9780198842255.003.0015","title":"Health Canada","year":2025,"lang":"en","type":"book-chapter","venue":"Pharmaceutical Medicine","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Scope (computer science); Clinical trial; Drug; Pharmacotherapy; MEDLINE; Public health; Drug trial","authors":[{"name":"Phil Ambery","is_ca":false},{"name":"Adrian Kilcoyne","is_ca":false},{"name":"Daniel O’Connor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5064515909366728,"gpt":0.5088575807551402,"spread":0.002405989818467402,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006851723,0.0007159007,0.000523928,0.001872668,0.004209255,0.004944681,0.001361216,0.002626228,0.4078565],"category_scores_gemma":[0.002935387,0.0005008199,0.0004923482,0.00295552,0.0007063992,0.0009118918,0.0009626413,0.002069877,0.1386225],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03791425,"about_ca_system_score_gemma":0.07443479,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9077642,"about_ca_topic_score_gemma":0.9547924,"domain_scores_codex":[0.9981433,0.00007834649,0.00004375452,0.0002020458,0.001184712,0.0003476901],"domain_scores_gemma":[0.9968956,0.0001574292,0.00005553768,0.00009554446,0.002372982,0.0004230021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000007122697,0.000006807923,0.0001641346,0.00005218678,0.000001638828,0.00003966698,0.00003187903,0.00003834772,0.00004531157,0.01049012,0.9651685,0.0239542],"study_design_scores_gemma":[0.000004413381,0.000002419812,0.0005035795,0.00005520834,0.000001314945,0.00002657331,0.00003139742,0.00003438428,0.00003605401,0.0004831264,0.9988174,0.000004130387],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0003592511,0.001870206,0.0002181318,0.007578113,0.0005572086,0.00006442412,0.01867609,0.0003269263,0.9703497],"genre_scores_gemma":[0.002431613,0.001043793,0.0003896782,0.002668158,0.000063028,0.00002597667,0.004749813,0.0001037576,0.988524],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.9620857,"threshold_uncertainty_score":0.8446208,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411639738","doi":"10.1007/s40290-025-00573-y","title":"Safety Warnings on the Same Harmful Effects of Medicines: A Comparison of Four National Regulators","year":2025,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; University of Sydney","keywords":"Pharmacology; Medicine; Environmental health; Business","authors":[{"name":"Lucy T Perry","is_ca":false},{"name":"Alice L Bhasale","is_ca":false},{"name":"Ashleigh Hooimeyer","is_ca":false},{"name":"Eliza J McEwin","is_ca":false},{"name":"Annim Mohammad","is_ca":false},{"name":"Barbara Mintzes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1384110428210106,"gpt":0.4996191888193955,"spread":0.3612081459983849,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05550114,0.0003949169,0.001351148,0.006936588,0.00158482,0.004315993,0.0013806,0.001775843,0.003714661],"category_scores_gemma":[0.2345005,0.0007908059,0.002676327,0.006071336,0.003197161,0.005766638,0.005873007,0.00186858,0.0005098784],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005671376,"about_ca_system_score_gemma":0.005402573,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009693021,"about_ca_topic_score_gemma":0.008660468,"domain_scores_codex":[0.9118456,0.04471876,0.01998631,0.00426923,0.01681929,0.002360837],"domain_scores_gemma":[0.734529,0.157697,0.06712006,0.007844892,0.02838027,0.004428731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01296934,0.001307227,0.8318918,0.006823492,0.003961667,0.0003988176,0.05069298,0.0007347676,0.001764735,0.00203726,0.002075418,0.08534239],"study_design_scores_gemma":[0.000905089,0.004842338,0.9193374,0.003359057,0.002755889,0.0006606684,0.04889407,0.001173956,0.001815769,0.0011171,0.01489215,0.0002466349],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867214,0.003837735,0.001019896,0.0006145209,0.00007159576,0.0009972557,0.001012408,0.00003083377,0.005694286],"genre_scores_gemma":[0.994655,0.001468995,0.001411677,0.0005579019,0.00004153422,0.0007482612,0.0006713302,0.00003778219,0.0004077089],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05550114,"threshold_uncertainty_score":0.2935216,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4242306480","doi":"10.1093/med/9780199609147.003.0012","title":"Health Canada","year":2013,"lang":"en","type":"book-chapter","venue":"Pharmaceutical Medicine","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Environmental science","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.1706395852564809,"gpt":0.5016619708817266,"spread":0.3310223856252457,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004175169,0.001068869,0.0007921706,0.002279949,0.004096414,0.004303912,0.001293717,0.002572676,0.5015486],"category_scores_gemma":[0.002048395,0.0006096276,0.0004590652,0.003899175,0.0007709761,0.001328291,0.001100232,0.002183381,0.2457913],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0179122,"about_ca_system_score_gemma":0.03863664,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8197761,"about_ca_topic_score_gemma":0.9237812,"domain_scores_codex":[0.999029,0.00005206961,0.0000230346,0.0001612335,0.000528392,0.0002062215],"domain_scores_gemma":[0.9987419,0.0001241794,0.00003253824,0.00005818935,0.0008274836,0.000215758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001258064,0.00001434115,0.0001754511,0.00004888392,0.000001929534,0.00003948274,0.00002433962,0.00005970238,0.00005039892,0.009069238,0.9470127,0.04349094],"study_design_scores_gemma":[0.000006772597,0.00000294528,0.0004653216,0.0000530902,0.00000204588,0.00002177228,0.00004266804,0.00006401214,0.00004586746,0.0009973347,0.9982936,0.000004489273],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0002588444,0.001624145,0.000232486,0.002985722,0.0005487215,0.00004210848,0.006074265,0.0002168929,0.9880167],"genre_scores_gemma":[0.0008184873,0.0007431003,0.0001707917,0.000716195,0.00003219303,0.00001352115,0.0009738705,0.00006652559,0.9964653],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.9820878,"threshold_uncertainty_score":0.7109804,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4416837248","doi":"10.1007/s40290-025-00593-8","title":"Considerations for Biosimilar Adoption in Pediatrics: A Scoping Review","year":2025,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biosimilar; Pharmacovigilance; New product development; Product (mathematics); Key (lock); MEDLINE; Drug development","authors":[{"name":"Elaine Lau","is_ca":true},{"name":"Alicia Koo","is_ca":true},{"name":"Meredith Ames","is_ca":true},{"name":"Cheyenne Matinnia","is_ca":true},{"name":"Avram Denburg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2351960777849705,"gpt":0.5185248198969498,"spread":0.2833287421119793,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009423128,0.0009749352,0.003400896,0.005268543,0.0005805456,0.004373503,0.001684555,0.003749408,0.004366699],"category_scores_gemma":[0.0199246,0.0006972788,0.002815646,0.005286918,0.001136389,0.003819629,0.001892014,0.003022669,0.0006825314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002730316,"about_ca_system_score_gemma":0.01051923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004335284,"about_ca_topic_score_gemma":0.01112557,"domain_scores_codex":[0.9965706,0.0008422403,0.001185011,0.0003834522,0.0008576374,0.0001610388],"domain_scores_gemma":[0.9812036,0.01364568,0.00277771,0.000190548,0.00183756,0.0003449192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002162071,0.00007002574,0.0007448666,0.2371867,0.0009147772,0.000292644,0.0002802958,0.0004017158,0.0005194513,0.004096312,0.01948758,0.7357894],"study_design_scores_gemma":[0.0001003637,0.0001232886,0.001582823,0.6202297,0.003859259,0.000855094,0.000416176,0.0001745253,0.0003515372,0.002219755,0.3700418,0.00004569424],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006867611,0.9990145,0.00005465946,0.000500984,0.0001100363,0.000009200046,0.00002059615,0.000002314333,0.0002190218],"genre_scores_gemma":[0.0007498629,0.998211,0.0002597301,0.000589686,0.00007657527,0.0000173146,0.00002465216,0.000001533701,0.00006959416],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009423128,"threshold_uncertainty_score":0.04983485,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}